北美細胞培養基市場規模、份額及趨勢分析報告－產業概況及2032年預測

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare North America Cell Culture Media Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

北美細胞培養基市場規模、份額及趨勢分析報告－產業概況及2032年預測

  • Healthcare
  • Published Report
  • Feb 2025
  • North America
  • 350 页面
  • 桌子數： 67
  • 图号： 33
  • Author : Sachin Pawar
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

North America Cell Culture Media Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 2.81 Billion USD 6.57 Billion 2024 2032
Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 2.81 Billion
Diagram Market Size (Forecast Year)
 USD 6.57 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Sartorius AG
  • Lonza Group AG
  • Cytiva

北美細胞培養基市場細分，按類型（化學定義培養基、經典培養基、無血清培養基、特種培養基、幹細胞培養基和溶源性肉湯 (LB)、客製化培養基配方等）、應用（生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、分銷和研究實驗室、醫院、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、分銷和研究實驗室、醫院、再生醫學與組織工程等 方法年

細胞培養基市場 Z

北美細胞培養基市場規模

  • 2024 年北美細胞培養基市場規模為28.1 億美元 ，預計 到 2032 年將達到 65.7 億美元，預測期內 複合年增長率為 11.20%。
  • 市場成長主要得益於生物製藥研發活動的增加，以及該地區生物製劑製造投資的擴大
  • 此外，對先進細胞療法和個人化醫療的需求不斷增長，也推動了對高品質專用培養基的需求。這些共同的驅動因素正在推動細胞培養基領域的重大進步和應用，從而推動區域市場的強勁擴張。

北美細胞培養基市場分析

  • 細胞培養基為體外細胞培養提供必需的營養物質和生長因子，因其在實現細胞持續高產生長方面發揮的作用，對學術和商業環境中的生物製藥研究、疫苗開發和細胞療法越來越重要
  • 細胞培養基需求的不斷增長主要源於生物製劑製造的快速擴張、個人化醫療的日益普及以及藥物研發和毒性測試中對細胞檢測的日益依賴
  • 美國在北美細胞培養基市場佔據主導地位，2024 年其收入份額最大，為 41.8%，這得益於政府的大力資助、生物製藥行業的蓬勃發展以及先進細胞培養技術的早期採用，尤其是在單克隆抗體和乾細胞研究相關的應用方面
  • 預計在預測期內，加拿大將成為北美細胞培養基市場成長最快的國家，這得益於再生醫學投資的增加、產學研合作的加強以及擴大生物技術基礎設施和創新中心的國家戰略
  • 無血清培養基在北美細胞培養基市場佔據主導地位，2024 年的市佔率為 45.1%，因其一致性、降低的污染風險以及適用於臨床和商業應用中可擴展的生物製造製程而受到青睞

報告範圍和北美細胞培養基市場細分  

屬性

北美細胞培養基關鍵市場洞察

涵蓋的領域
  • 依類型：化學成分培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯（Lb）、客製化培養基配方等
  • 依應用：生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等
  • 按最終用戶：生物製藥公司、生物技術組織、學術和研究實驗室、醫院、診斷中心、細胞庫、法醫實驗室等。
  • 按分銷管道：直接投標、第三方分銷和零售

覆蓋國家

北美洲

  • 我們
  • 加拿大
  • 墨西哥

主要市場參與者
  • 賽默飛世爾科技公司（美國）
  • 默克集團（德國）
  • 賽多利斯股份公司（德國）
  • 龍沙集團（瑞士）
  • Cytiva（美國）
  • HiMedia Laboratories Pvt. Ltd.（印度）
  • 康寧公司（美國）
  • 富士膠片爾灣科學公司（美國）
  • Repligen公司（美國）
  • BD（美國）
  • Eppendorf SE（德國）
  • PromoCell GmbH（德國）
  • PAN-Biotech GmbH（德國）
  • CellGenix GmbH（德國）
  • 丹納赫公司（美國）
  • GE醫療生命科學（美國）
  • Bio-Rad Laboratories, Inc.（美國）
  • Takara Bio Inc.（日本）
  • Miltenyi Biotec GmbH（德國）
  • MP Biomedicals, LLC（美國）

市場機會
  • 不斷加強的合作與夥伴關係
  • 生物製藥和疫苗需求增加

加值資料資訊集

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深入的專家分析、定價分析、品牌份額分析、消費者調查、人口統計分析、供應鏈分析、價值鏈分析、原材料/消耗品概述、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

北美細胞培養基市場趨勢

“轉向無血清和化學成分培養基”

  • 北美細胞培養基市場的一個重要且加速的趨勢是向無血清和化學成分確定的培養基的轉變，這是由於研究和製造環境中對一致、無污染和符合法規的解決方案的需求日益增長所推動的
    • 例如，賽默飛世爾科技提供針對特定細胞類型優化的各種無血清和無異源配方，而 Cytiva 則開發了化學成分明確的培養基，支持生物製劑生產的高密度培養
  • 這種轉變提高了產品的可重複性、批次間一致性，並降低了動物性成分污染的風險。此外，FDA 和加拿大衛生部等監管機構越來越青睞化學成分明確的製劑，用於臨床和 GMP 應用。
  • 無血清培養基可以更好地控制細胞培養條件，符合遠離動物成分的道德規範，支持可持續和標準化的生物生產
  • 龍沙和默克等公司正在大力投資開發先進的培養基平台，為幹細胞、CAR-T 療法和疫苗生產提供客製化解決方案，這反映​​了市場朝著專業化、性能優化配方發展的更廣泛趨勢
  • 隨著各機構致力於開發可擴展、高效的流程，以適應不斷發展的治療和研究需求，學術界和商業領域對無血清和化學成分確定的培養基的需求正在迅速增長

北美細胞培養基市場動態

司機

“美國和加拿大生物製劑和細胞研究的成長”

  • 生物製劑、個人化醫療和再生療法的蓬勃發展是北美對先進細胞培養基需求不斷增長的關鍵驅動力
    • 例如，2024 年 5 月，賽默飛世爾科技擴大了其位於紐約的生產設施，以滿足疫苗和細胞療法中使用的無動物源性培養基日益增長的需求，從而增強了區域製造能力
  • 美國擁有強大的醫藥生態系統和高額研發支出，正在推動大規模採用無血清和 GMP 級培養基進行單株抗體生產、免疫療法和毒理學測試
  • 加拿大也透過增加對幹細胞研究的投資、大學主導的生物技術計畫以及旨在促進生命科學創新的政府支持的資助計畫來促進成長
  • 細胞培養基與癌症生物學、病毒學和生物製劑製造等廣泛應用的兼容性使其成為商業和學術生物工藝的基礎工具

克制/挑戰

“成本高且監管要求複雜”

  • 開發和生產無血清、化學成分明確或 GMP 級培養基的成本相對較高，這對其採用構成了障礙，特別是對於小型實驗室和早期生物技術公司而言
    • 例如，製造商必須滿足 FDA 和加拿大衛生部製定的嚴格監管標準，包括嚴格的驗證、可追溯性和文件記錄，這會增加營運複雜性和生產成本
  • 這項挑戰對於從研究級培養基過渡到臨床級培養基的設施尤其重要，因為合規負擔可能會限制靈活性並減緩擴大規模的過程
  • 規模較小的機構可能難以獲得或負擔 CAR-T 細胞擴增或基因編輯工作流程等高級應用所需的客製化培養基解決方案
  • 為了克服這些障礙，企業正致力於透過在地化生產、模組化製造以及更廣泛地獲取符合科學和監管要求的經過驗證的可擴展培養基選項來提高成本效益

北美細胞培養基市場範圍

市場根據類型、應用、最終用戶和分銷管道進行細分。

  • 按類型

根據類型，北美細胞培養基市場細分為化學成分確定的培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯 (LB)、客製化培養基配方等。 2024 年，無血清培養基佔據了最大的收入份額，達到 45.1%，這得益於其在臨床和商業生物製造中的廣泛應用，因為它具有更高的一致性、更低的污染風險以及合規性。生物製藥生產中對無動物性產品的需求日益增長，進一步推動了無血清製劑的採用。

預計化學成分限定培養基領域將在2025年至2032年間實現最快的增長，因為研究機構和生物製藥公司對高度一致且可重複的培養基的需求日益增長，這些培養基可用於單克隆抗體生產和細胞療法開發等高級應用。化學成分限定培養基的精準性和可自訂性使其能夠實現可擴展的高性能細胞培養，這推動了其快速發展。

  • 按應用

根據應用，北美細胞培養基市場細分為生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等。由於對疫苗、單株抗體和細胞療法等生物製劑的需求迅速增長，生物製藥生產領域在2024年佔據了市場主導地位。該領域受益於對生物相似藥和疫苗生產的大規模投資，尤其是在美國，生物製劑在美國製藥收入中佔了相當大的份額。

由於幹細胞治療和個人化醫療領域的研發不斷增加，再生醫學和組織工程領域預計將在預測期內實現最高的複合年增長率。人們越來越關注開發針對慢性和退化性疾病的細胞治療方式，這推動了對高品質、專用培養基配方的需求。

  • 按最終用戶

根據最終用戶，北美細胞培養基市場細分為生物製藥公司、生物技術機構、學術和研究實驗室、醫院、診斷中心、細胞庫、法醫實驗室等。生物製藥公司在2024年佔據最大份額，因為它們是上游加工和大規模生物製劑生產所需的細胞培養基的主要消費者。美國生物製劑臨床試驗和產品線的不斷增加，大大鞏固了其市場主導地位。

預計學術和研究實驗室領域將在預測期內呈現最快的成長，這得益於大學和公共資助機構（尤其是在加拿大）持續進行的研究計畫。再生醫學和癌症生物學領域的創新進一步刺激了學術領域的媒體需求。

  • 按分銷管道

根據分銷管道，北美細胞培養基市場細分為直接招標、第三方分銷和零售。 2024年，直接招標管道佔據了最大的收入份額，這得益於培養基製造商與主要生物製藥公司、醫院和學術機構之間的長期供應協議。這些合約提供基於批量的採購和監管級品質保證，使其成為關鍵應用的首選。

預計第三方分銷領域將在預測期內以最快的速度成長，因為小型生物技術公司和研究實驗室依賴分銷商提供靈活的採購、技術支援以及更廣泛的產品選擇，而無需簽訂直接供應商協議。北美專業生命科學分銷商的滲透率不斷提高，進一步支撐了這一趨勢。

北美細胞培養基市場區域分析

  • 美國在北美細胞培養基市場佔據主導地位，2024 年其收入份額最高，為 41.8%，這得益於政府的大力資助、生物製藥行業的蓬勃發展以及先進細胞培養技術的早期採用，尤其是在單克隆抗體和乾細胞研究相關的應用方面
  • 該國用戶優先考慮高品質、無血清、化學成分明確的培養基，用於從疫苗生產到再生醫學等各種應用，並得到尖端製造設施和學術研究中心的支持
  • 政府的優惠資金、強勁的臨床試驗活動以及賽默飛世爾科技和通用電氣醫療等主要參與者的存在進一步鞏固了這一領導地位，使美國成為細胞培養基領域創新和應用的中心樞紐

美國細胞培養基市場洞察

2024年，美國細胞培養基市場佔據北美地區最大收入份額，達41.8%，這得益於生物製藥行業的強勁需求以及細胞療法研究的不斷拓展。美國強大的臨床試驗生態系統、學術研究能力以及政府支持的資助計劃，將繼續支持無血清和化學成分確定培養基的廣泛應用。此外，賽默飛世爾科技和龍沙等主要參與者的加入，以及對生物製劑生產基礎設施的大量投資，推動了商業和學術應用的持續成長。

加拿大細胞培養基市場洞察

受幹細胞研究、個人化醫療和產學研合作投資增加的推動，加拿大細胞培養基市場預計將在預測期內實現顯著的複合年增長率。政府旨在促進生命科學創新和擴大生物製造產能的措施進一步增強了市場發展勢頭。加拿大各機構越來越多地採用先進的、符合GMP標準的培養基進行再生醫學、腫瘤學研究和疫苗開發，這推動了公共和私營部門對高品質定製製劑的需求不斷增長。

墨西哥細胞培養基市場洞察

受墨西哥生物技術和生命科學活動擴張的推動，墨西哥細胞培養基市場預計將在預測期內實現強勁的複合年增長率。在政府計畫和公私合作的支持下，癌症、傳染病和再生醫學領域的學術研究投入不斷增加，促進了高性能細胞培養基的廣泛應用。當地生物製藥和合約研究組織 (CRO) 正在將無血清培養基和特種培養基整合到其開發工作流程中，而墨西哥作為北美生物製劑生產合作夥伴的地位日益提升，也凸顯了對可靠且符合 GMP 標準的培養基配方的需求。

北美細胞培養基市場份額

北美細胞培養基產業主要由知名公司主導，包括：

  • 賽默飛世爾科技公司（美國）
  • 默克集團（德國）
  • 賽多利斯股份公司（德國）
  • 龍沙集團（瑞士）
  • Cytiva（美國）
  • HiMedia Laboratories Pvt. Ltd.（印度）
  • 康寧公司（美國）
  • 富士膠片爾灣科學公司（美國）
  • Repligen公司（美國）
  • BD（美國）
  • Eppendorf SE（德國）
  • PromoCell GmbH（德國）
  • PAN-Biotech GmbH（德國）
  • CellGenix GmbH（德國）
  • 丹納赫公司（美國）
  • GE醫療生命科學（美國）
  • Bio-Rad Laboratories, Inc.（美國）
  • Takara Bio Inc.（日本）
  • Miltenyi Biotec GmbH（德國）
  • MP Biomedicals, LLC（美國）

北美細胞培養基市場的最新發展是什麼？

  • 2024年4月，賽默飛世爾科技宣布擴建其位於紐約州大島的工廠，以提高無動物源性和化學成分明確的細胞培養基的產量。此舉旨在滿足疫苗製造商和細胞療法開發商日益增長的需求，鞏固賽默飛世爾科技在北美地區提供高品質、符合GMP標準的培養基解決方案的領先地位，並支持先進治療應用的可擴展性。
  • 2024年3月，GE醫療旗下Cytiva部門與多倫多大學的「Medicine by Design」計畫合作，共同開發專為再生醫學研究量身打造的幹細胞培養基。此次合作體現了GE醫療對產學研合作創新的承諾，以及透過優化、可客製化的培養基平台推動下一代療法的發展。
  • 2024年2月，龍沙集團擴建了位於新罕布夏州朴茨茅斯的生物生產基地，以增強其生產臨床級和商業級生物製劑培養基的能力。這項投資重點在於提升無血清和化學成分明確的製劑產能，旨在滿足北美生物製藥客戶對單株抗體和細胞療法產品線日益增長的需求。
  • 2024年1月，Avantor公司推出了一系列性能增強型經典培養基，專為細胞分析和臨床前藥物開發而設計。該產品面向美國製藥研究實驗室，強調批次間一致性和降低污染風險，支援在受監管環境中進行藥物發現和高通量篩選工作流程。
  • 2023年12月，康寧公司宣布與加拿大生技新創公司進行一項策略合作，共同開發用於3D細胞培養和類器官生長的培養基補充劑。該合作旨在推進體外疾病建模和藥物測試，滿足加拿大各地癌症生物學和個人化醫療應用對複雜培養基系統日益增長的需求。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA CELL CULTURE MEDIA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 NORTH AMERICA CELL CULTURE MEDIA MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE

6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE

6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS

6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH CONTAMINATION

6.2.2 HIGH COST OF PRODUCTION

6.3 OPPORTUNITIES

6.3.1 RISING COLLABORATION AND PARTNERSHIPS

6.3.2 INCREASING DEMAND FOR BIOPHARMACEUTICALS AND VACCINES

6.3.3 INNOVATIONS IN 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 COMPLEXITY OF MEDIA FORMULATION

6.4.2 INTENSE MARKET COMPETITION

7 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE

7.1 OVERVIEW

7.2 CHEMICALLY DEFINED MEDIA CHEMICALLY DEFINED MEDIA

7.3 CLASSICAL MEDIA

7.4 SERUM-FREE MEDIA

7.5 SPECIALTY MEDIA

7.6 STEM CELL MEDIA

7.7 LYSOGENY BROTH (LB)

7.8 CUSTOM MEDIA FORMULATION

7.9 OTHERS

8 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BIOPHARMACEUTICAL PRODUCTION

8.3 DRUG SCREENING & DEVELOPMENT

8.4 DIAGNOSTICS

8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING

8.6 OTHERS

9 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER

9.1 OVERVIEW

9.2 BIOPHARMACEUTICAL COMPANIES

9.3 BIOTECHNOLOGY ORGANIZATIONS

9.4 ACADEMIC AND RESEARCH LABORATORIES

9.5 HOSPITALS

9.6 DIAGNOSTIC CENTERS

9.7 CELL BANKS

9.8 FORENSIC LABORATORIES

9.9 OTHERS

10 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 THIRD PARTY DISTRIBUTION

10.4 RETAILS SALES

11 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY REGION

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA CELL CULTURE MEDIA MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 MERCK KGAA

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 DANAHER CORPORATION (CYTIVA)

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SARTORIUS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 LONZA

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 CORNING INCORPORATED

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 COMPANY SHARE ANALYSIS

14.6.4 PRODUCT PORTFOLIO

14.6.5 RECENT UPDATES

14.7 AJINOMOTO CO., INC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AKRON BIOTECH

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BD

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT UPDATES

14.1 BIO-RAD LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.11 CAISSON LABS INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT UPDATES

14.12 CELL APPLICATION, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT UPDATES

14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 FUJIFILM HOLDINGS CORPORATION

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT UPDATES

14.15 HIMEDIA LABORATORIES

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT UPDATES

14.16 KOH JIN-BIO CO., LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT UPDATES

14.17 PAN-BIOTECH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT UPDATES

14.18 PROMOCELL GMBH

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT UPDATES

14.19 SERA-SCANDIA A/S

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STEMCELL TECHNOLOGIES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TAKARA BIO INC.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 GMP REQUIREMENTS

TABLE 2 SCOPE OF THE CURRENT DOCUMENT

TABLE 3 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 4 NORTH AMERICA CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 5 NORTH AMERICA CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 6 NORTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 7 NORTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 8 NORTH AMERICA SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 9 NORTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 10 NORTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 11 NORTH AMERICA LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 12 NORTH AMERICA CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 13 NORTH AMERICA OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 14 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 15 NORTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 16 NORTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 17 NORTH AMERICA DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 18 NORTH AMERICA DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 19 NORTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 20 NORTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 21 NORTH AMERICA OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 22 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 23 NORTH AMERICA BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 24 NORTH AMERICA BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 25 NORTH AMERICA ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 26 NORTH AMERICA HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 27 NORTH AMERICA DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 28 NORTH AMERICA CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 29 NORTH AMERICA FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 30 NORTH AMERICA OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 31 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 32 NORTH AMERICA DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 33 NORTH AMERICA THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 34 NORTH AMERICA RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 35 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 36 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 37 NORTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 38 NORTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 39 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 40 NORTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 41 NORTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 42 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 43 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 44 U.S. CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 45 U.S. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 46 U.S. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 47 U.S. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 48 U.S. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 49 U.S. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 50 U.S. CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 51 U.S. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 52 CANADA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 53 CANADA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 54 CANADA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 55 CANADA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 56 CANADA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 57 CANADA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 58 CANADA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 59 CANADA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 60 MEXICO CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 61 MEXICO SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 62 MEXICO STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 63 MEXICO CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 64 MEXICO BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 65 MEXICO REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 66 MEXICO CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 67 MEXICO CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CELL CULTURE MEDIA MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CELL CULTURE MEDIA MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CELL CULTURE MEDIA MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 NORTH AMERICA CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS BY KEY PLAYERS

FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE NORTH AMERICA CELL CULTURE MEDIA MARKET FROM 2025 TO 2035

FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CELL CULTURE MEDIA MARKET IN 2025 AND 2035

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CELL CULTURE MEDIA MARKET

FIGURE 16 NORTH AMERICA CELL CULTURE MEDIA MARKET: BY TYPE, 2024

FIGURE 17 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2025-2035

FIGURE 18 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, CAGR, 2025-2035

FIGURE 19 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, LIFE LINE CURVE

FIGURE 20 NORTH AMERICA CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024

FIGURE 21 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION,2025-2035

FIGURE 22 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, CAGR (2025-2035)

FIGURE 23 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, LIFE LINE CURVE

FIGURE 24 NORTH AMERICA CELL CULTURE MEDIA MARKET: BY END-USER, 2024

FIGURE 25 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END USER, (2025-2035)

FIGURE 26 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, CAGR (2025-2035)

FIGURE 27 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, LIFE LINE CURVE

FIGURE 28 NORTH AMERICA CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 29 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL,2025-2035

FIGURE 30 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, CAGR, (2025-2035)

FIGURE 31 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, LIFE LINE CURVE

FIGURE 32 NORTH AMERICA CELL CULTURE MEDIA MARKET: SNAPSHOT (2024)

FIGURE 33 NORTH AMERICA CELL CULTURE MEDIA MARKET: COMPANY SHARE 2024 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 北美細胞培養基市場細分，按類型（化學定義培養基、經典培養基、無血清培養基、特種培養基、幹細胞培養基和溶源性肉湯 (LB)、客製化培養基配方等）、應用（生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、分銷和研究實驗室、醫院、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、分銷和研究實驗室、醫院、再生醫學與組織工程等 方法年 进行细分的。
在2024年，北美細胞培養基市場的规模估计为2.81 USD Billion美元。
北美細胞培養基市場预计将在2025年至2032年的预测期内以CAGR 11.2%的速度增长。
市场上的主要参与者包括Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Lonza Group AG, Cytiva 。

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future